Daniel Aghion's most recent trade in Oramed Pharmaceuticals, Inc was a trade of 30,000 Common Stock done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Oramed Pharmaceuticals Inc | Daniel Aghion | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 30,000 | 68,820 (0%) | 0% | - | Common Stock | |
| Oramed Pharmaceuticals Inc | Daniel Aghion | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 8,371 | 77,191 (0%) | 0% | - | Common Stock | |
| Oramed Pharmaceuticals Inc | Aghion Daniel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2024 | 3,750 | 38,820 (0%) | 0% | - | Common Stock | |
| Oramed Pharmaceuticals Inc | Aghion Daniel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 30,000 | 30,000 (0%) | 0% | - | Common Stock | |
| Oramed Pharmaceuticals Inc | Aghion Daniel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 5,070 | 35,070 (0%) | 0% | - | Common Stock |